Your browser doesn't support javascript.
loading
Real-world data on T-DM1 efficacy - results of a single-center retrospective study of HER2-positive breast cancer patients.
Hardy-Werbin, Max; Quiroga, Vanesa; Cirauqui, Beatriz; Romeo, Margarita; Felip, Eudald; Teruel, Iris; Garcia, Juan Jose; Erasun, Carlos; España, Sofia; Cucurull, Marc; Montprade, Elisabeth; Pardo, Juan Carlos; Carballo, Dania; Velarde, Jose Maria; Margeli, Mireia.
Afiliación
  • Hardy-Werbin M; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
  • Quiroga V; B-ARGO Group, Institut Català d'Oncologia, Medical Oncology Service, Hospital Germans Trias i Pujol, Badalona, Spain.
  • Cirauqui B; B-ARGO Group, Institut Català d'Oncologia, Medical Oncology Service, Hospital Germans Trias i Pujol, Badalona, Spain.
  • Romeo M; B-ARGO Group, Institut Català d'Oncologia, Medical Oncology Service, Hospital Germans Trias i Pujol, Badalona, Spain.
  • Felip E; B-ARGO Group, Institut Català d'Oncologia, Medical Oncology Service, Hospital Germans Trias i Pujol, Badalona, Spain.
  • Teruel I; B-ARGO Group, Institut Català d'Oncologia, Medical Oncology Service, Hospital Germans Trias i Pujol, Badalona, Spain.
  • Garcia JJ; B-ARGO Group, Institut Català d'Oncologia, Medical Oncology Service, Hospital Germans Trias i Pujol, Badalona, Spain.
  • Erasun C; B-ARGO Group, Institut Català d'Oncologia, Medical Oncology Service, Hospital Germans Trias i Pujol, Badalona, Spain.
  • España S; B-ARGO Group, Institut Català d'Oncologia, Medical Oncology Service, Hospital Germans Trias i Pujol, Badalona, Spain.
  • Cucurull M; B-ARGO Group, Institut Català d'Oncologia, Medical Oncology Service, Hospital Germans Trias i Pujol, Badalona, Spain.
  • Montprade E; B-ARGO Group, Institut Català d'Oncologia, Medical Oncology Service, Hospital Germans Trias i Pujol, Badalona, Spain.
  • Pardo JC; B-ARGO Group, Institut Català d'Oncologia, Medical Oncology Service, Hospital Germans Trias i Pujol, Badalona, Spain.
  • Carballo D; Escuela de Medicina y Ciencias de la Salud, Tecnológico de Monterrey, Mexico.
  • Velarde JM; Statistical Department, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP), Medical Oncology Service, Hospital Germans Trias i Pujol, Badalona, Spain.
  • Margeli M; B-ARGO Group, Institut Català d'Oncologia, Medical Oncology Service, Hospital Germans Trias i Pujol, Badalona, Spain. mmargeli@iconcologia.net.
Sci Rep ; 9(1): 12760, 2019 09 04.
Article en En | MEDLINE | ID: mdl-31484985
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Trastuzumab / Maitansina Tipo de estudio: Observational_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Sci Rep Año: 2019 Tipo del documento: Article País de afiliación: España
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Trastuzumab / Maitansina Tipo de estudio: Observational_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Sci Rep Año: 2019 Tipo del documento: Article País de afiliación: España